旋切联合药物涂层球囊治疗髂动脉及下肢动脉支架内完全闭塞
本研究分析旋切联合药物涂层球囊(DCB)治疗髂动脉和/或下肢动脉支架内完全闭塞的长期结局。74例连续患者接受Rotarex系统与DCB血管成形术,手术成功率98.6%,12个月再狭窄率20.5%,仅手术并发症是1年复发性再狭窄的独立预测因素。
要点
- 旋切联合DCB治疗支架内完全闭塞手术成功率高(98.6%)。
- 12个月再狭窄率20.5%,靶病变血运重建率5.5%。
- 术中并发症是1年复发性再狭窄的独立预测因素(OR 63.3)。
核心结论
- 旋切联合DCB治疗支架内完全闭塞可获得满意结局,12个月复发性再狭窄率可接受。
研究设计与样本
- 回顾性分析2014年4月至2017年6月74例连续患者(平均年龄66.7±9.7岁,49例男性)的支架内完全闭塞。
- 所有患者接受Rotarex系统旋切联合DCB血管成形术。
主要发现
- 总体手术成功73例(98.6%)。
- 6例(8.1%)危重肢体缺血患者出现远端栓塞,经溶栓治疗缓解。
- 3例(4.1%)夹层未需治疗,1例(1.4%)穿孔需植入覆膜支架。
- 33例(44.6%)患者额外植入支架,主要因结果欠佳(28例)或并发症(5例,包括覆膜支架)。
- 12个月双功超声评估再狭窄率20.5%(15/73),4例(5.5%)接受靶病变血运重建。
关键数值与推荐
- 复发性再狭窄在Rutherford 5级缺血(p=0.005)、急诊手术(p=0.021)、涉及3个独立血管段的广泛手术(p=0.016)及术中发生并发症(p<0.001)的患者中更常见。
- 多因素分析中,仅术中并发症是1年复发性再狭窄的独立预测因素(OR 63.3,95%CI 5.7至701.5)。
临床怎么用
- 旋切联合DCB可作为支架内完全闭塞的治疗选择,但需注意术中并发症风险。
- 术中并发症的发生显著增加1年复发性再狭窄风险,应积极预防和处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze the long-term outcomes of a hybrid treatment method combining rotational atherectomy with drug-coated balloon (DCB) angioplasty in patients with total in-stent occlusion in the iliac and/or infrainguinal arteries. MATERIALS AND METHODS: Between April 2014 and June 2017, 74 consecutive patients (mean age 66.7±9.7 years; 49 men) with total occlusion of a previously implanted stent underwent endovascular recanalization using the Rotarex system and DCB angioplasty. Half (37, 50%) of the patients had critical limb ischemia (CLI), and 30 (41%) of the procedures were performed in emergency. Mean lesion length was 22±15 cm. RESULTS: Overall procedure success was achieved in 73 (98.6%) patients. Six (8.1%) CLI patients developed distal embolism that responded to thrombolysis. Three (4.1%) dissections did not require treatment, while 1 (1.4%) perforation necessitated stent-graft implantation. In all, 33 (44.6%) patients had an additional stent implanted, mainly due to a suboptimal outcome (n=28) or complications (n=5 including the stent-graft). The restenosis rate assessed by duplex ultrasound at 12 months was 20.5% (15/73); 4 (5.5%) patients underwent target lesion revascularization. Recurrent restenosis was more frequent in patients with Rutherford category 5 ischemia (p=0.005), in emergency procedures (p=0.021), after extensive procedures involving 3 independent vessel segments (p=0.016), and if a complication arose during the procedure (p<0.001). In multivariate analysis, only occurrence of a procedural complication was an independent predictor of recurrent restenosis at 1 year (OR 63.3, 95% CI 5.7 to 701.5). CONCLUSION: These findings imply that rotational atherectomy and DCB angioplasty may provide satisfactory outcomes in the treatment of total in-stent occlusion, with a satisfactory recurrent restenosis rate at 12 months.
引用
- Milnerowicz A, Milnerowicz A, Kuliczkowski W, et al. Rotational Atherectomy Plus Drug-Coated Balloon Angioplasty for the Treatment of Total In-Stent Occlusions in Iliac and Infrainguinal Arteries. J Endovasc Ther. 2019. PMID: 30907258. doi:10.1177/1526602819836749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。